Correction: Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401
Clin Cancer Res. 2024 Oct 1;30(19):4542.
doi: 10.1158/1078-0432.CCR-24-2408.